Insulet (PODD) Tops Q1 EPS by 17c; Guides

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to Insulet (PODD) Tops Q1 EPS by 17c; Guides

Insulet Reports First Quarter 2022 Revenue Increase of 17% Year-Over-Year

May 5, 2022 4:01 PM EDT

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months ended March 31, 2022.

First Quarter Financial Highlights:

First quarter 2022 revenue of $295.4 million, up 17.1%, or 19.3% in... More